ZEB2 and acute myeloid leukemia: Our work with Rosa26-based transgenic overexpression models would suggest equal detrimental effects of Zeb1 overexpression as Zeb2 on myeloid differentiation, and our work would tend to support previous reports that Zeb1 can act as an oncogene in certain forms of AML [11].